Conduct Phase III CT: CDSCO Panel Tells Sun Pharma on FDC Relugolix plus Estradiol plus Norethindrone Acetate Tablets Dr. Divya Colin10 Jan 2024 6:00 PM ISTNew Delhi: Citing that there is no safety and efficacy data on Indian population, the Subject Expert Committee (SEC) functional under the Central Drug...
Sun Pharma gets CDSCO Panel Nod To Manufacture and market antianxiety drug Etifoxine HCl Capsule Dr. Divya Colin2 Jan 2024 6:00 PM ISTNew Delhi: Pharmaceutical major, Sun Pharma has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Sun Pharma to buy 16.7 percent stake in Lyndra Therapeutics for Rs 249 crore Ruchika Sharma19 Dec 2023 2:44 PM ISTThe transaction is expected to be completed by the end of December 2023, subject to certain conditions, Sun Pharma added.
Lupin, Sun Pharma recall rheumatoid arthritis, thyroid drugs in US Ruchika Sharma18 Dec 2023 11:45 AM ISTNew Delhi: Leading drugmakers Sun Pharma and Lupin are recalling products in the US market over manufacturing issues, as per the US Food and Drug...
Sun Pharma Ilumetri now included in category B of China National Reimbursement Drug List Ruchika Sharma14 Dec 2023 2:43 PM ISTILUMETRI is indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.
Sun Pharma arm signs licensing agreement with Aclaris Therapeutics Ruchika Sharma6 Dec 2023 12:30 PM ISTThe agreement includes an upfront payment of USD 15 million, regulatory and commercial milestones, and royalties.
Exclude patients above 65 years of age: CDSCO Panel Tells Sun Pharma on Eluxadoline trial Dr. Divya Colin25 Nov 2023 6:00 PM ISTNew Delhi: Responding to the drug major Sun Pharma's proposal to manufacture and market Eluxadoline tablets 75 mg and 100 mg, the Subject Expert...
Sun Pharma, WOTR to create over 5.2 billion litres of water harvesting capacity in rural Maharashtra Ruchika Sharma13 Nov 2023 9:30 AM ISTPune: WOTR (Watershed Organisation Trust) has announced a pivotal partnership with Sun Pharma. The three-year programme aims to address the...
Sun Pharma gets CDSCO nod to manufacture, market FDC Silodosin JP plus Tadalafil Dr. Divya Colin7 Nov 2023 5:30 PM ISTNew Delhi: Based on the Phase III Clinical trial (CT) of the Fixed Dose Combination (FDC) Silodosin JP plus Tadalafil presented by the drug major Sun...
Sun Pharma reports bigger-than-expected rise in Q2 profit Ruchika Sharma1 Nov 2023 12:30 PM ISTThe company's generic version of popular cancer drug Revlimid is also a significant contributor to the total sales.
Sun Pharma to now offer Desidustat, first oral treatment for CKD-associated anaemia in India under brand Rytstat Ruchika Sharma30 Oct 2023 12:50 PM ISTMumbai: Strengthening its position in the chronic kidney disease space, Sun pharma is now going to offer Desidustat, the first-of-its-kind oral...
Sun Pharma arm recalls 144 bottles of anti-depression medicine in US over manufacturing issue Ruchika Sharma20 Oct 2023 11:37 AM ISTNew Delhi: Drug major Sun Pharmaceutical Industries Inc has recalled 144 bottles of a generic anti-depression medicine from the US market due to...
